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Abstract 
BACKGROUND: In the last two decades, there has been increasing evidence to 
suggest that trigeminal neuralgia (TN) may be linked to a dysfunction of the 
autonomic nervous system (ANS).  The aim of the present study was to formally test 
this hypothesis by comparing the reactivity of the ANS to experimental pain in a 
population of TN patients and healthy controls.  METHODS: Twelve patients 
diagnosed with classical TN and 12 healthy controls participated in the study.  
Cardiac activity was assessed while participants were instructed to rest and again 
during a cold pressor test (CPT).  Heart rate variability analyses were performed off-
line to obtain parasympathetic (high-frequency) and sympathetic (low-frequency) 
indices.  RESULTS: At baseline, ANS measures did not differ between healthy 
controls and TN patients, and both groups showed a similar increase in heart rate 
during the CPT (all p-values > .05).  However, TN patients showed a greater increase 
in cardiac sympathetic activity and a greater decrease in cardiac parasympathetic 
activity during CPT compared to healthy controls (all p-values < .05).  Importantly, 
changes in sympathetic reactivity, from baseline to CPT, were negatively associated 
with the number of pain paroxysms experienced each day by TN patients in the 
preceding week (r = -.58, p < .05).  CONCLUSION: These results suggest that TN, 
like many other short-lasting, unilateral facial pain conditions, is linked to ANS 
alterations.  Future studies are required to determine if the altered ANS response 
observed in TN patients is a cause or a consequence of TN pain. 
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1. Introduction
Trigeminal neuralgia (TN) is a rare neuropathic pain disorder affecting the 
fifth cranial nerve and characterized by sharp paroxystic pain episodes lasting from a 
few seconds to two minutes1, 2. Although TN was described several decades ago3, 4, its
physiopathology remains poorly understood5-7. According to Dandy8 and Janetta9, 10,
TN is caused by a microvascular-induced compression of the dorsal root of the 
trigeminal nerve, most commonly from the superior cerebellar artery. Despite its 
popularity, the microvascular compression hypothesis has been challenged by several 
studies showing that: (a) many patients suffering from TN do not show evidence of 
microvascular compression11, 12, and (b) microvascular compression is present in a
large proportion of individuals who do not suffer from TN13-16.
In the last two decades, several reports have suggested that TN could be linked 
to impaired autonomic nervous system (ANS) activity17-22. Until recently, however,
evidence of ANS dysregulation in TN remained mostly speculative or anecdotal.  For 
example, Noguchi et al.17 reported the case of a 29 year-old woman suffering from
symptomatic TN who was significantly relieved following a stellate ganglion block (a 
sympathetic ganglion). Similar results were reported by Manahan et al.21 following a
sphenopalatine ganglion block (a parasympathetic ganglion) on a 56 year-old woman. 
More recently, Simms and colleagues23 sent questionnaires and reviewed the
medical records of 92 TN patients. They noted that a majority of these patients (i.e., 
67% of the patients sampled) had at least one autonomic symptom associated with 
their pain.  Although some patients reported regional sweating (a symptom which can 
be linked to sympathetic activation), the vast majority reported parasympathetic-like 
symptoms (e.g., excessive salivation, nasal congestion, excessive tearing). Taken 
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together, these observations support the idea that TN could be linked to ANS 
dysfunctions, and prod researchers to pursue future work to better understand the role 
of the ANS in TN pain. 
A next logical step to the study of Simms and colleagues23 would be to
evaluate the activity and reactivity of the ANS in a population of patients suffering 
from TN using objective sympathetic and parasympathetic measures. In this regard, 
heart rate variability (HRV) techniques, allowing the recording of both sympathetic 
and parasympathetic indices24, seem particularly appropriate. To our knowledge, no
previous study used HRV techniques to evaluate the reactivity of cardiac ANS 
responses in patients with TN.  Given this knowledge gap, the aim of this study was to 
assess and compare the reactivity of the ANS to experimental pain in a population of 
TN patients and healthy controls using HRV analyses. Based on the results of Simms 
et al., we postulated that TN patients would show increased sympathetic and/ or 
parasympathetic reactivity when compared to healthy controls. 
2. Methods
2.1 Participants 
Twelve patients diagnosed with classical TN and 12 healthy controls 
participated in this study (mean age ± SD = 62 ± 11 yrs) (see Table 1). TN patients 
were recruited from the list of patients scheduled for Gamma-knife surgery (GKS) at 
the GKS clinic of the Sherbrooke University Hospital. Diagnosis of classical TN was 
confirmed by a neurosurgeon using the International Classification of Headache 
Disorders criteria25. Patients with atypical or symptomatic TN (e.g. TN secondary to
multiple sclerosis) or with symptoms suggesting post-herpetic or deafferentation pain 
syndromes were excluded. None of our retained participants showed evidence of 
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tactile, thermal or pricking hypoesthesia. None showed signs of dysesthesia, 
hyperesthesia or allodynia. In addition to undergoing a conventional and sensory-
specific neurological examination (conducted by both the appointed neurosurgeon and 
GL), every participant underwent magnetic resonance imaging (MRI) to rule out 
possible neuronal damage. 
Healthy controls were recruited through local ads and were all community-
dwelling individuals. They all had good general health and none suffered from a 
painful condition, with the exception of three participants who reported minor 
osteoarthritic pain. Every participant was asked to refrain from using short-term 
analgesics two hours before testing and from drinking coffee and smoking cigarettes 
six hours before testing. TN patients were also asked to stop all pain medications for a 
period of 24h before their appointment to minimize the effect that medication could 
have on pain perception and ANS measures. Group and patient characteristics are 
listed in Tables 1 and 2. 
The experiment took place at the Centre de recherche du Centre hospitalier 
universitaire de Sherbrooke (Sherbrooke, Quebec, Canada). The local institutional 
ethics committee approved the study's procedures and each participant provided 
informed written consent before participating. 
2.2 Experimental pain: cold pressor test 
Participants were asked to immerse their right arm for 5 min in a bath of 
circulating cold water maintained at 10C. This procedure, commonly known as the 
cold pressor test (CPT), was used to trigger ANS responses to pain. Every 30 s, 
patients rated their immersion-induced pain intensity using a 0-100 numerical rating 
scale (NRS; 0 = no pain; 100 = intolerable pain). 
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2.3 Cardiac activity 
Five-minute electrocardiogram (ECG) recordings were obtained during 
baseline testing (rest) and during experimental pain testing. Heart rate (HR) was 
monitored with a three lead (ECG) montage and sampled at 1000 Hz using a 
PowerLab recording system with Chart software (AD Instruments, Colorado). 
Instantaneous RR intervals were obtained from the ECG waveform with a peak 
detection algorithm to detect successive R-waves. All data were manually checked to 
ensure that only normal to normal (NN) intervals were analyzed. We analyzed HRV 
in the frequency domain. Specifically, fast Fourier transforms were used to calculate 
the power spectral density of HR oscillations. Two components can be distinguished 
from short-term spectrum analysis of HRV: a low frequency (LF) (0.04 - 0.15Hz) and 
a high frequency (HF) (0.15 - 0.4Hz) component. These two components are used as 
indices of cardiac autonomic nervous system activity24. HR fluctuations in the LF
range reflect baroreflex-mediated sympathetic activity associated with Mayer waves 
of blood pressure26, 27. On the other hand, HRV in the HF range is generated by
respiratory sinus arrhythmia (RSA) and constitutes a sensitive measure of cardiac 
vagal parasympathetic activity28, 29. Normalized HF and LF values were computed
and analysed. Sympathovagal LF/HF ratios were not analysed because the 
sympathovagal balance indexed by the LF/HF ratio is already accounted for when 
normalizing HF and LF values30.
2.4 Data analysis 
Autonomic reactivity to pain was evaluated by calculating the delta score 
between baseline and CPT induced responses [delta score = (CPT – baseline)]. Heart 
rate and HRV delta scores were compared between the two groups using independent 
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t-tests. In order to examine the relationships between ANS reactivity to experimental 
pain and the characteristics of TN patients, we performed Pearson correlational 
analyses between the change in LF and HF observed from baseline to CPT and a 
series of demographic and clinical variables obtained at the moment of the 
experiment. These demographic and clinical variables included the age and sex of the 
patient, disease duration, average intensity of pain paroxysms experienced in the 
preceding week (0-100 NRS), and the average number of daily pain paroxysms 
experienced in the preceding week. Statistical significance was set at p < 0.05. All 
tests were performed using SPSS (version 18.0 for Windows®, Chicago, IL, USA). 
Because of the relatively small number of subjects included in the study and in 
spite of histograms suggesting the presence of normally distributed data, non-
parametric tests were additionally used to compare HR and HRV measures between 
the two groups (Mann-Whitney tests) and to evaluate the association between the 
HRV measures and the clinico-demographic variables (Spearman tests). Results 
confirmed no difference between parametric and non-parametric approaches. 
Therefore, only parametric statistics are reported. 
3. Results
3.1 Pain perception 
Every participant experienced the CPT as a painful procedure. The mean pain 
intensity score during the CPT was comparable between the two groups (mean ± SD = 
48 ± 27 for healthy controls and 63 ± 26 for TN patients; t = -1.42; p = .17). None of 
the TN participants experienced facial pain during the testing session. 
3.2 Cardiac HR responses 
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No difference in HR (both at rest and during CPT) was observed between the 
two groups. Healthy controls and TN patients showed a similar increase in HR during 
the CPT (see Table 3). 
3.3 Autonomic activity and reactivity to pain 
There was no difference in resting sympathetic (LF) or parasympathetic 
activity (HF) between healthy controls and TN patients (see Table 4). However, 
during the CPT, TN patients showed a greater increase in LF (t = -2.60, p < .05) and a 
greater decrease in HF (t = 2.23; p < .05) when compared to healthy controls, 
indicating greater increment in sympathetic activity and greater decrement in 
parasympathetic activity during experimental pain, respectively (see Figures 1 and 2). 
To extend the results obtained with the LF and HF measures, and better 
understand the role of the ANS in TN, we further explored HRV analysis in the time 
domain. More specifically, we calculated the root mean-square of successive 
differences between adjacent normal-to-normal (NN) intervals (RMSSD), the number 
of pairs of adjacent NN intervals differing by more than 50 ms (pNN50) and the 
standard deviation of NN intervals (SDNN) 31, 32 and compared results between the
two groups of participants. Contrary to LF and HF analyses, no significant group 
differences were noted for RMSSD, pNN50 and SDNN (all p-values > .05). 
 3.4 Associations between HRV measures and clinico-demographic variables 
The correlation coefficients obtained between the HRV measures and the 
demographic and clinical variables obtained at the moment of the experiment are 
presented in Table 5. As can be seen from this table, there was a negative association 
between the CPT-induced change in LF activity and the average number of daily pain 
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paroxysms experienced by the patients in the preceding week. No other significant 
results were observed (all other p-values > .05). 
4. Discussion
The purpose of this study was to test for differences in pain-evoked ANS 
activity between TN patients and healthy controls. Results indicate that TN patients 
and healthy controls have comparable autonomic cardiac responses at rest, but that in 
response to a tonic experimental pain challenge, TN patients show greater 
sympathetic arousal and parasympathetic withdrawal than healthy controls. The 
results also revealed the presence of an association between sympathetic reactivity to 
pain and the number of pain paroxysms experienced each day by TN patients in the 
preceding week. Surprisingly, the direction of the association suggests that the ANS 
of patients with few pain paroxysms is more reactive to experimental pain than the 
ANS of patients with frequent pain paroxysms. The exact reason for the negative 
association between sympathetic reactivity and the number of pain paroxysms 
experienced by TN patients remains unclear and surely merits future attention. 
4.1 Cause or consequence 
At this point, it is difficult to determine if the altered autonomic reactivity to 
pain observed in TN patients is a cause or a consequence of TN pain. Some may for 
instance suggest that the increased sympathetic reactivity observed in TN patients 
represents a pathophysiological feature of TN, responsible (alone or combined with 
other factors) for the occurrence of pain episodes. This hypothesis can be supported 
by the observations of Noguchi et al.17, who reported clinical improvement (i.e.,
decreased pain) in a TN patient following a sympathetic ganglion block. 
Others, alternately, might argue that the differences noted in TN patients could 
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be attributable to an adaptation of the nervous system in response to the frequent pain 
paroxysms experienced by these individuals. Somewhat supportive of this view are 
the results of Chalaye et al.33 who noted the presence a positive relationship between
the sympathetic response and the efficacy of pain inhibitory mechanisms (both 
triggered by the same CPT). In this regard, the increased sympathetic response noted 
in TN patients could be seen as an effective strategy to alleviate pain. Such an 
interpretation could help to explain why the number of pain paroxysms noted in this 
study in TN patients was lower in those with high sympathetic arousal. Future 
research is essential to better understand the link that exists between TN pain and 
ANS dysfunction. 
4.2 Trigeminal neuralgia and trigeminal autonomic cephalalgias 
In 1997, Goadsby and Lipton suggested that many headache disorders could 
be grouped together based on the presence of prominent autonomic features34.
Goadsby and Lipton used the appellation “trigeminal autonomic cephalalgia” (TAC) 
to describe this group of headaches, characterized by short-lasting, unilateral and 
extremely severe pain associated with blatant cranial autonomic symptoms (e.g., 
tearing, ptosis, rhinorrhea). Today, the appellation TAC is a widely accepted 
throughout the medical community, and includes disorders such as cluster headache 
(CH), chronic paroxysmal hemicrania (CPH), and short-lasting unilateral 
neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) 
syndrome34. Despite the similarities between these disorders and TN (i.e., short-
lasting and severe pain usually affecting one side of the face), TN was not classified 
under the TAC family, largely because of the absence of salient autonomic features34, 
35. The present results, as well as the observations of Simms et al.23, challenge this
view by showing that TN may also be linked with autonomic features. 
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4.3 Chronic pain syndromes and ANS dysfunctions 
Autonomic dysfunctions have been documented in numerous other painful 
conditions, including irritable bowel syndrome (IBS)36, fibromyalgia (FM)37, complex
regional pain syndrome (CRPS)38, temporomandibular disorder (TMD)39 and cluster
headaches (CH)40. For instance, studies looking at ANS arousal among FM patients
found that these patients have increased sympathetic and decreased parasympathetic 
activity at rest37, 41-44. FM patients also exhibit greater sympathetic and weaker
parasympathetic cardiac reactivity during painful stimuli45, a pattern of changes which
is associated to increased HR response to pain (see del Paso et al.46 and Chalaye et
al.45).  On their side, Tousignant-Laflamme et al.36 noted that IBS patients and healthy
controls had an opposite autonomic response during the CPT, that is decreased 
parasympathetic/ increased sympathetic reactivity for healthy controls and increased 
parasympathetic/ decreased sympathetic reactivity for IBS patients.  Compared to 
healthy controls, IBS patients also showed a lower HR response during the CPT36.
Finally, in an elegant study published by Tassorelli et al.40, the authors recorded the
pupillary and cardiovascular (blood pressure) responses to the CPT in a population of 
CH individuals and healthy controls. Compared to the healthy controls, CH patients 
had an abnormal pupillary and cardiovascular response, pointing towards a general 
sympathetic hyperactivation and concomitant pupillary sympathetic hypofunction. 
In the present study, there was no difference between TN patients and healthy 
controls for the ANS measures recorded at rest, but we observed a similar pattern to 
that of del Paso et al.46, Chalaye et al.45 and Tassorelli et al.40 during exposure to a
painful stimulus (i.e., decreased parasympathetic and/ or increased sympathetic 
reactivity to pain in pain patients compared to healthy controls). However, contrary to 
Chalaye et al.45, Reyes del Paso et al.46 and Tousignant-Laflamme et al.36, we
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observed no difference in HR between pain patients and healthy controls. The 
similarities and differences observed between the current results (obtained in a TN 
population), and the results of Chalaye et al.45 and Reyes del Paso et al.46 (FM
population), Tousignant-Laflamme36 (IBS population) and Tassorelli et al. 40 (CH
population) suggest that autonomic abnormalities are probably a common feature of 
many painful conditions, but that each condition has a distinct ANS dysfunction 
profile. 
4.4 Limitations 
An important limitation of the present study concerns the relatively small 
number of participants tested. Small sample size impedes the statistical power of the 
analyses, thus increasing the probability of committing a type II error. Perhaps a 
larger sample size would have allowed us to detect other ANS abnormalities (e.g., 
between-group differences in sympathetic and parasympathetic activity at rest). 
Future studies need to be carried-out before any final conclusion can be made 
regarding the exact pattern of ANS dysregulation in TN. 
It must also be mentioned that the results of the present study are derived from 
a single autonomic test and a limited number of ANS measures. Of importance, the 
differences observed between the healthy controls and TN individuals were noted 
only for the LF and HF measures; no significant group differences being present for 
the other time domain variables (RMSSD, pNN50, SDNN). Several other tests (e.g., 
cold face test, slow deep breathing) and measures (e.g., skin blood flow, 
pupillometry) can been used to evaluate the activity and reactivity of the ANS (see for 
instance Hilz & Dutsch32). The use of the cold face test could provide more
information on the role of the parasympathetic nervous system in the pathophysiology 
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of TN47, 48. However, the possibility of triggering intense pain episodes in TN
individuals with a cold face test is quite high, hence raising important ethical and 
scientific concerns about the use of cold face tests in this population. Other tests 
evaluating parasympathetic reactivity (e.g., slow deep breathing, Valsalva maneuver) 
should perhaps be preferred. 
Moreover, the continued use of medication in the group of TN patients raises 
the possibility that the pattern of ANS results observed is due to medication use rather 
than to the presence or absence of TN. In a recent review, Lotufo et al.31 observed a
trend for higher baseline LF values in patients with epilepsy receiving anticonvulsant 
drugs. In the present study, we observed no difference in resting autonomic indices 
between healthy controls and TN patients. We also asked TN patients to stop all pain 
medications (including anti-epileptic drugs) for a period of 24h before their 
appointment. Nevertheless, given the long half-life of anti-epileptic drugs49, we
cannot exclude the possibility that anti-epileptic drugs are contributing to the 
observed effects. Future studies should be wary of this potential confound. 
5. Conclusion
In the present study, we sought to compare the autonomic reactivity to pain 
between TN patients and healthy controls. Our results showed that, for a comparable 
degree of experimental pain, TN patients showed greater increase in cardiac 
sympathetic activity and a greater decrease in cardiac parasympathetic activity during 
CPT compared to healthy controls. Although it is unclear if this altered autonomic 
response to experimental pain is also present during TN pain paroxysms, the present 
pattern of results opens interesting research avenues for the understanding of TN 
physiopathology and for the development of new treatment approaches (e.g., 
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sympathetic blockers) to ease TN symptoms. 
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Table 1. Group characteristics 
Healthy 
participants 
(n=12) 
TN patients 
(n=12) 
p-value 
Gender 5 males 9 males .18 
Age (years, mean ± SD) 65 ± 10 60 ± 12 .29 
Side affected - 6 Left - 
Territory affected - V1 = 1 
V2 = 5 
V3 = 1 
V1, V2 = 1 
V2, V3 = 4 
- 
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Table 2. Patients characteristics 
Patient 
number 
Age (yrs)/ 
gender 
Affected 
side 
Affected 
territory 
Medications 
(daily doses) 
1 67/ ♂ Left V2 Gabapentine 1200 mg BID 
Pregabalin 300 mg BID 
Naproxen 500 mg PRN 
2 69/ ♂ Right V2, V3 Pregabalin 150 mg BID 
3 78/ ♂ Left V2 Oxcarbazepine 150 mg BID 
4 66/ ♂ Left V2, V3 Gabapentine 300 mg QID 
Carbamazepine 200 mg TID 
Topiramate 100 mg TID 
5 59/ ♂ Right V2 Carbamazepine 1200 mg TID 
Acetylsalicylic acid 325 mg QD 
6 53/ ♂ Left V2 Gabapentine 300 mg TID 
7 65/ ♂ Left V1 Oxcarbazepine 600 mg TID 
8 59/ ♂ Right V2, V3 Oxcarbazepine 900 mg BID 
Baclofen 20 mg TID 
9 42/ ♀ Left V2, V3 Oxcarbazepine 300 mg TID 
10 65/ ♂ Right V1, V2 Oxacarbazepine 600 mg TID 
11 33/ ♀ Right V3 Carbamazepine 1200 mg BID 
Pregabalin 75 mg BID 
12 59/ ♀ Right V2 Oxacarbazepine 150 mg BID 
Pregabalin 75 mg BID 
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Table 3. Heart rate (mean ± SD) 
Healthy participants 
(n=12) 
TN patients 
(n=12) 
t-score p-value 
Resting heart rate 
(BPM) 
66 ± 10 67 ± 12 -0.29 .78 
Heart rate during 
CPT (BPM) 
71 ± 11 70 ± 12 0.17 .87 
Change in heart 
rate (CPT – rest; 
BPM) 
5 + 3 3 ± 4 1.38 .18 
BPM: beats per minute 
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Table 4. Baseline HRV values 
 Healthy 
participants 
(n=12) 
 
TN patients 
(n=12) 
t-score p-value 
Resting sympathetic 
activity (LF) 
(normalized unit, mean 
± SD) 
 
63 ± 27 48 ± 23 1.52 .14 
Resting parasympathetic 
activity (HF) 
(normalized unit, mean 
± SD) 
 
31 ± 23 45 ± 23 -1.46 .16 
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Table 5. Relationships between HRV measures and clinico-demographic variables 
Change in sympathetic activity p-value Change in parasympathetic activity p-value 
Age† r = -0.09 .69 r = -0.09 .67 
Sex†† t = -0.88 .39 t = 0.82 .42 
Disease duration (month) † r = -0.26 .40 r = 0.74 .11 
Average number of daily pain 
paroxysms in the preceding 
week† 
r = -0.58 .049 r = 0.42 .18 
Mean pain intensity of pain 
paroxysms experienced in the 
preceding week (0 -100) † 
r = 0.49 .11 r = 0.26 .41 
† Pearson correlation; †† independent t-test 
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Figure captions 
Figure 1. Mean change in low frequency (LF) between baseline (resting condition) 
and CPT.  Both healthy controls and TN patients had an increase in sympathetic 
activity (LF) during CPT.  TN patients showed a greater increase in sympathetic 
activity when compared to healthy controls (* p < .05). 
Figure 2. Mean change in high frequency (HF) between baseline (resting condition) 
and CPT.  Both healthy controls and TN patients showed a decrease in 
parasympathetic activity (HF) during CPT.  TN patients showed a greater decrease in 
parasympathetic activity when compared to healthy controls (* p < .05). 
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Figure 1. Change in sympathetic activity (LF) during CPT 
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Figure 2. Change in parasympathetic activity (HF) during CPT 
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